Research
Print page Print page
Switch language
The Capital Region of Denmark - a part of Copenhagen University Hospital
Published

Aberrant regulation of epigenetic modifiers contributes to the pathogenesis in patients with selenoprotein N-related myopathies

Research output: Contribution to journalJournal articleResearchpeer-review

DOI

  1. Multigenic truncation of the semaphorin-plexin pathway by a germline chromothriptic rearrangement associated with Moebius syndrome

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Toward mechanistic models for genotype-phenotype correlations in phenylketonuria using protein stability calculations

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. BRCA1 and BRCA2 5' noncoding region variants identified in breast cancer patients alter promoter activity and protein binding

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. A mutation update on the LDS-associated genes TGFB2/3 and SMAD2/3

    Research output: Contribution to journalJournal articleResearchpeer-review

  5. The BRCA2 c.68-7T > A variant is not pathogenic: A model for clinical calibration of spliceogenicity

    Research output: Contribution to journalJournal articleResearchpeer-review

  1. Hydroxylated Long-Chain Acylcarnitines are Biomarkers of Mitochondrial Myopathy

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. MSTO1 mutations cause mtDNA depletion, manifesting as muscular dystrophy with cerebellar involvement

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Growth and differentiation factor 15 as a biomarker for mitochondrial myopathy

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. Fat oxidation is impaired during exercise in lipin-1 deficiency

    Research output: Contribution to journalJournal articleResearchpeer-review

  • Christoph Bachmann
  • Faiza Noreen
  • Nicol C Voermans
  • Primo L Schär
  • John Vissing
  • Johanna M Fock
  • Saskia Bulk
  • Benno Kusters
  • Steven A Moore
  • Alan H Beggs
  • Katherine D Mathews
  • Megan Meyer
  • Casie A Genetti
  • Giovanni Meola
  • Rosanna Cardani
  • Emma Mathews
  • Heinz Jungbluth
  • Francesco Muntoni
  • Francesco Zorzato
  • Susan Treves
View graph of relations

Congenital myopathies are early onset, slowly progressive neuromuscular disorders of variable severity. They are genetically and phenotypically heterogeneous and caused by pathogenic variants in several genes. Multi-minicore Disease, one of the more common congenital myopathies, is frequently caused by recessive variants in either SELENON, encoding the endoplasmic reticulum glycoprotein selenoprotein N or RYR1, encoding a protein involved in calcium homeostasis and excitation-contraction coupling. The mechanism by which recessive SELENON variants cause Multiminicore disease (MmD) is unclear. Here, we extensively investigated muscle physiological, biochemical and epigenetic modifications, including DNA methylation, histone modification, and noncoding RNA expression, to understand the pathomechanism of MmD. We identified biochemical changes that are common in patients harboring recessive RYR1 and SELENON variants, including depletion of transcripts encoding proteins involved in skeletal muscle calcium homeostasis, increased levels of Class II histone deacetylases (HDACs) and DNA methyltransferases. CpG methylation analysis of genomic DNA of patients with RYR1 and SELENON variants identified >3,500 common aberrantly methylated genes, many of which are involved in calcium signaling. These results provide the proof of concept for the potential use of drugs targeting HDACs and DNA methyltransferases to treat patients with specific forms of congenital myopathies.

Original languageEnglish
JournalHuman Mutation
Volume40
Issue number7
Pages (from-to)962-974
Number of pages13
ISSN1059-7794
DOIs
Publication statusPublished - Jul 2019

ID: 58148463